Portfolio → AlphaRose Therapeutics

AlphaRose Therapeutics

AlphaRose Therapeutics is building a new model for rare-disease drug development, bringing personalized genetic medicines to children that traditional pharma overlooks. Founded by entrepreneur and musician Casey McPherson after his daughter Rose's diagnosis, it combines antisense oligonucleotide (ASO) technology, AI-driven discovery, and a novel commercialization strategy to slash the cost and timeline of treating ultra-rare disease.

Visit AlphaRose Therapeutics

Ziora Bio

ZIORA is developing a first-in-class fertility platform that improves egg quality and ovarian health by targeting the mitochondrial dysfunction and cellular aging behind reproductive decline. Rather than managing the consequences of reproductive aging, it works to improve the biological quality of eggs themselves, improving IVF outcomes with early commercial traction in international markets.

Biopharma

Suncoast Ventures

Building something that matters in health?

Get in touch